New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
12:38 EDTUSNA, GOOG, DDD, MYGN, MRK, BIRT, CVS, SSYSOn The Fly: Midday Wrap
Stocks on Wall Street were mixed at midday after ADP reported that dismal weather in January put a damper on private sector hiring. The market seemed indecisive in the opening 30 minutes of trading, but soon picked up downside momentum. The Nasdaq, which was down more than 1% early in the session, has trimmed its losses and the Dow has moved into positive ground, though just barely. ECONOMIC EVENTS: In the U.S., payroll company ADP reported that 175,000 service jobs were created in January, versus the expectations for 185,000 net new positions to have been added. The ISM services index rose to 54.0 in January from December's 53.0 reading, which was a bit ahead of expectations. COMPANY NEWS: Dow component Merck (MRK) advanced fractionally after the drug company’s quarterly results were generally in-line with expectations and it also announced three clinical collaboration agreements to evaluate its investigational anti-PD-1 immunotherapy… Shares of Google (GOOG) are advancing in a down market after the search giant reached a settlement with European Union regulators over antitrust allegations and research firm Bernstein hiked its price target on the stock to $1,500 from $1,350... CVS Caremark (CVS) announced plans to cease selling all tobacco products, including cigarettes, at all its locations starting October 1. MAJOR MOVERS: Among the notable gainers was multi-level-marketer USANA Health Sciences (USNA), which rose 17% after its results and guidance beat expectations. Also higher were shares of molecular diagnostic company Myriad Genetics (MYGN), which climbed over 11% after the company reported second quarter results that beat consensus expectations, raised its fiscal 2014 outlook, and announced the acquisition of Crescendo Bioscience. Among the noteworthy losers was 3D Systems (DDD), which plunged 16% after the maker of 3D printers and supplies lowered its profit outlook for the current fiscal year and guided to earnings next year below the consensus estimate. A number of 3D Systems’ peers fell as well, with the next biggest company in the sector, Stratasys (SSYS), also declining 3%. Also lower were shares of Actuate (BIRT), which slid about 17% after reporting earnings, announcing the acquisition of German software developer legodo ag and being downgraded at Drexel Hamilton. INDICES: Near midday, the Dow was up 13.12, or 0.08%, to 15,458.36; the Nasdaq was down 13.59, or 0.34%, to 4,017.93; and the S&P 500 was down 2.14, or 0.12%, to 1,753.06.
News For DDD;SSYS;MRK;GOOG;CVS;MYGN;USNA;BIRT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
January 21, 2015
08:07 EDTGOOGUSPTO Examiner reconfirms patentability of Netlist's LRDIMM patent claims
Netlist (NLST) announced that the Examiner in the consolidated reexamination of U.S. Pat. No. 7,619,912 issued an Answer maintaining the patentability of 92 claims related to LRDIMM. The reexaminations were brought in the United States Patent and Trademark Office by Google (GOOG), Inphi Corporation, and SMART Modular Technologies. The 92 patentable claims are generally directed to the fundamental concept of rank multiplication which is integral to the design of the LRDIMM. The Examiner issued the Answer on January 14, 2015, in response to voluminous appeal briefs filed by Google, Inphi, and SMART Modular. The Examiner considered arguments from all parties and ultimately maintained his conclusions as to the patentability of these claims, while maintaining the rejection of 11 other claims. The parties will now have the opportunity to file rebuttal briefs before the reexamination proceeds to the Patent Trial and Appeals Board for oral arguments, likely later this year or early next. The '912 Patent is also the subject of litigation between Netlist and Google in the Northern District of California and Netlist and Inphi in the Central District of California. Both sets of litigation have been stayed pending the outcome of this and other reexamination proceedings.
08:02 EDTMRKMerck completes tender offer to acquire Cubist
Merck (MRK) announced the successful completion of the tender offer for all of the outstanding shares of common stock of Cubist Pharmaceuticals (CBST) at a purchase price of $102.00 per share. As of the tender offer expiration yesterday, 58,039,667 shares of common stock of Cubist were validly tendered and not properly withdrawn from the tender offer, representing approximately 75.7% of the outstanding common stock of Cubist on a fully diluted basis. All of such shares have been accepted for payment in accordance with the terms of the tender offer, and Merck expects to promptly pay for all such shares. Following consummation of the tender offer, Merck expects to complete the acquisition of Cubist later today through a merger of Merck’s wholly owned subsidiary with and into Cubist without stockholder approval. Upon completion of the merger, all outstanding shares of common stock of Cubist, other than shares held by Cubist in treasury or shares held by Cubist’s stockholders who are entitled to and properly exercise appraisal rights under Delaware law, will be canceled and converted into the right to receive cash equal to the $102.00 offer price per share without interest, less any applicable withholding taxes. In addition, upon completion of the merger, Cubist will become a wholly owned subsidiary of Merck and the common stock of Cubist will cease to be traded on the NASDAQ Stock Market.
07:37 EDTCVSCVS Health initiated with an Overweight at Stephens
Subscribe for More Information
07:09 EDTDDD, SSYSPiper positive on Stratasys, cautious on 3D Systems after survey
Subscribe for More Information
06:05 EDTCVSCVS Health upgraded to Buy from Neutral at Goldman
Goldman upgraded CVS to Buy based on strong leverage to Rx growth and Specialty, procurement savings upside, and capital deployment optionality. Price target raised to $113 from $95.
January 20, 2015
18:45 EDTGOOGSpaceX raises $1B, Google, Fidelity to own slightly under 10%, Bloomberg says
Elon Musk's Space Exploration Technologies Corp. has sold an approximately 10% stake to Google (GOOG) and Fidelity for $1B, Bloomberg reports. Reference Link
17:18 EDTMRKDana Holding to replace Cubist in S&P 400 as of 1/22 close
Subscribe for More Information
16:34 EDTGOOGSpacex has raised $1B, Google and Fidelity to own slightly under 10%
Subscribe for More Information
11:25 EDTGOOGGoogle partners with Cloudera to bring Cloud Dataflow to Spark
Subscribe for More Information
11:21 EDTGOOGYouTube plans launch of original content initiative by end of 2015, Variety says
Subscribe for More Information
10:15 EDTDDD3D Systems call activity attributed to takeover speculation
3D Systems January weekly 29 and 30 calls are active on total call volume of 8,600 contracts (900 puts) on renewed takeover speculation. January weekly call option implied volatility is at 78, February is at 53, March is at 56; compared to its 26-week average of 47 according to Track Data. Active call volume suggests traders taking positions for price movement.
10:07 EDTDDDRumor: 3D Systems strength attributed to takeover speculation
Shares of 3D Systems are moving higher on speculation the company has hired an investment bank to review a potential sale of the company.
07:23 EDTMRKMerck funding testing of lower dosages of Zilmax, Reuters reports
Subscribe for More Information
07:07 EDTMYGNMyriad RBM joins Institut Pasteur in TB collaboration
Myriad RBM, a wholly owned subsidiary of Myriad Genetics, announced that it will assist the Institut Pasteur in a public-private research collaboration to fight the global tuberculosis, or TB, epidemic. This research project is funded by the Bill & Melinda Gates Foundation through a grant to the Institut Pasteur. The proof-of-concept study will evaluate patients with latent and active TB infections who are affiliated with the South African Tuberculosis Vaccine Initiative clinical study sites. The goals of this study are to field-test Myriad RBM's TruCulture system as a point-of-care blood collection and immune response monitoring method and to stratify patients with active and latent tuberculosis.
07:00 EDTGOOGEU official calls on Google to make more concessions, NY Times says
Subscribe for More Information
January 19, 2015
17:57 EDTGOOGGoogle near $1B investment in SpaceX, WSJ reports
Google is near an agreement to invest $1B in Elon Musk's SpaceX, Wall Street Journal reports, citing a person familiar with the matter. The investment would value SpaceX at more than $10B, the Journal adds. The Information earlier today reported Google was near an investment in SpaceX, but did not specify the amount. Reference Link
12:29 EDTGOOGGoogle near investment in Musk's SpaceX, The Information reports
Subscribe for More Information
January 18, 2015
13:45 EDTGOOGGoogle in talks to acquire mobile-pay platform Softcard, WSJ says
Subscribe for More Information
January 16, 2015
09:09 EDTGOOGYouTube to host Super Bowl halftime show
YouTube will host a Halftime Show produced in collaboration with Collective Digital Studio that will be live streamed on the AdBlitz Channel, the Google (GOOG, GOOGL) property announced in a blog post. The show will feature more than 20 YouTube creators and musicians with over 60M combined subscribers, YouTube stated. The Super Bowl is being broadcast on Sunday, Feb. 1 on Comcast's (CMCSA) NBC Network. Reference Link
07:33 EDTGOOGAlign Technology near-term risk/reward less favorable, says Credit Suisse
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use